Inceptionr LLC Sells 9,853 Shares of Dolby Laboratories, Inc. (NYSE:DLB)

Inceptionr LLC lowered its stake in Dolby Laboratories, Inc. (NYSE:DLB - Free Report) by 78.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,734 shares of the electronics maker's stock after selling 9,853 shares during the quarter. Inceptionr LLC's holdings in Dolby Laboratories were worth $236,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently modified their holdings of DLB. Vanguard Group Inc. increased its stake in Dolby Laboratories by 3.3% in the 3rd quarter. Vanguard Group Inc. now owns 6,389,084 shares of the electronics maker's stock valued at $506,399,000 after buying an additional 205,319 shares during the period. Kayne Anderson Rudnick Investment Management LLC raised its holdings in shares of Dolby Laboratories by 4.8% during the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 5,246,122 shares of the electronics maker's stock worth $415,808,000 after acquiring an additional 239,578 shares in the last quarter. Morgan Stanley boosted its position in Dolby Laboratories by 11.9% during the third quarter. Morgan Stanley now owns 4,902,295 shares of the electronics maker's stock valued at $388,556,000 after purchasing an additional 523,250 shares during the last quarter. Ninety One UK Ltd grew its stake in Dolby Laboratories by 29.0% in the fourth quarter. Ninety One UK Ltd now owns 2,572,346 shares of the electronics maker's stock valued at $221,685,000 after purchasing an additional 578,239 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in Dolby Laboratories by 1.5% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 681,152 shares of the electronics maker's stock worth $58,702,000 after purchasing an additional 10,389 shares during the last quarter. Hedge funds and other institutional investors own 58.56% of the company's stock.

Wall Street Analysts Forecast Growth

DLB has been the subject of several research reports. StockNews.com upgraded Dolby Laboratories from a "hold" rating to a "buy" rating in a report on Saturday, May 11th. Rosenblatt Securities reiterated a "buy" rating and issued a $98.00 target price on shares of Dolby Laboratories in a research note on Monday, April 29th.

Dolby Laboratories Stock Up 0.3 %

Shares of DLB traded up $0.24 during mid-day trading on Friday, hitting $83.86. 404,317 shares of the company's stock were exchanged, compared to its average volume of 373,865. The firm has a fifty day moving average of $81.87 and a two-hundred day moving average of $83.42. Dolby Laboratories, Inc. has a twelve month low of $75.87 and a twelve month high of $91.01. The stock has a market cap of $8.04 billion, a price-to-earnings ratio of 42.79 and a beta of 0.98.

Dolby Laboratories Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 22nd. Stockholders of record on Tuesday, May 14th will be paid a dividend of $0.30 per share. The ex-dividend date is Monday, May 13th. This represents a $1.20 annualized dividend and a dividend yield of 1.43%. Dolby Laboratories's dividend payout ratio (DPR) is 61.22%.

Dolby Laboratories Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.